REVVITY, INC Current Portion of Long-Term Debt
REVVITY, INC (RVTY) had Current Portion of Long-Term Debt of $572.16 million as of 2026-07-05, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt, Current Maturities
us-gaap:LongTermDebtCurrent · last filed 2026-08-11
- 2026-07-05: Long-term Debt, Current Maturities $572.16M.
- 2026-04-05: Long-term Debt, Current Maturities $575.83M.
- 2025-12-28: Long-term Debt, Current Maturities $588.83M.
- 2025-09-28: Long-term Debt, Current Maturities $583.84M.
| Period end | Long-term Debt, Current Maturities |
|---|---|
| 2026-07-05 | $572.16M 10-Q · filed 2026-08-11 |
| 2026-04-05 | $575.83M 10-Q · filed 2026-05-12 |
| 2025-12-28 | $588.83M 10-Q · filed 2026-08-11 |
| 2025-09-28 | $583.84M 10-Q · filed 2025-11-04 |
| 2025-06-29 | $230.00K 10-Q · filed 2025-08-05 |
| 2025-03-30 | $242.00K 10-Q · filed 2025-05-06 |
| 2024-12-29 | $242.00K 10-K · filed 2026-02-24 |
| 2024-09-29 | $1.04M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $711.41M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $711.44M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $721.87M 10-K · filed 2025-02-25 |
| 2023-10-01 | $727.54M 10-Q · filed 2023-11-07 |
| 2023-07-02 | $478.94M 10-Q · filed 2023-08-09 |
| 2023-04-02 | $479.42M 10-Q · filed 2023-05-12 |
| 2023-01-01 | $470.93M 10-K · filed 2024-02-27 |
| 2022-10-02 | $503.55M 10-Q · filed 2022-11-14 |
| 2022-07-03 | $4.18M 10-Q · filed 2022-08-09 |
| 2022-04-03 | $3.73M 10-Q · filed 2022-05-10 |
| 2022-01-02 | $4.24M 10-Q · filed 2022-11-14 |
| 2021-10-03 | $4.49M 10-Q · filed 2021-11-09 |
| 2021-07-04 | $4.67M 10-Q · filed 2021-08-10 |
| 2021-04-04 | $358.44M 10-Q · filed 2021-05-11 |
| 2021-01-03 | $380.95M 10-K · filed 2022-03-03 |
| 2020-10-04 | $360.22M 10-Q · filed 2020-11-10 |
| 2020-07-05 | $346.34M 10-Q · filed 2020-08-11 |
| 2020-04-05 | $9.65M 10-Q · filed 2020-05-12 |
| 2019-12-29 | $9.97M 10-Q · filed 2020-11-10 |
| 2019-09-29 | $506.65M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $8.21M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $13.33M 10-Q · filed 2019-05-07 |
| 2018-12-30 | $14.86M 10-Q · filed 2019-11-05 |
| 2018-09-30 | $20.07M 10-Q · filed 2018-11-06 |
| 2018-07-01 | $17.32M 10-Q · filed 2018-08-07 |
| 2018-04-01 | $217.75M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $217.31M 10-Q · filed 2018-11-06 |
| 2017-10-01 | $1.29M 10-Q · filed 2017-11-07 |
| 2017-07-02 | $2.23M 10-Q · filed 2017-08-08 |
| 2017-04-02 | $2.19M 10-Q · filed 2017-05-09 |
| 2017-01-01 | $1.17M 10-Q · filed 2017-11-07 |
| 2016-10-02 | $1.16M 10-Q · filed 2016-11-08 |
| 2016-07-03 | $1.15M 10-Q · filed 2016-08-09 |
| 2016-04-03 | $1.14M 10-Q · filed 2016-05-10 |
| 2016-01-03 | $1.12M 10-Q · filed 2016-11-08 |
| 2015-10-04 | $1.11M 10-Q · filed 2015-11-10 |
| 2015-06-28 | $1.97M 10-Q · filed 2015-08-04 |
| 2015-03-29 | $1.08M 10-Q · filed 2015-05-05 |
| 2014-12-28 | $1.07M 10-Q · filed 2015-11-10 |
| 2014-09-28 | $1.16M 10-Q · filed 2014-11-04 |
| 2014-06-29 | $1.05M 10-Q · filed 2014-08-05 |
| 2014-03-30 | $2.63M 10-Q · filed 2014-05-06 |
| 2013-12-29 | $2.62M 10-Q · filed 2014-11-04 |
| 2013-09-29 | $2.62M 10-Q · filed 2013-11-05 |
| 2013-06-30 | $2.21M 10-Q · filed 2013-08-06 |
| 2013-03-31 | $7.30M 10-Q · filed 2013-05-06 |
| 2012-12-30 | $1.77M 10-Q · filed 2013-11-05 |
| 2012-09-30 | $1.47M 10-Q · filed 2012-11-06 |
| 2012-01-01 | $0.00 10-Q · filed 2012-11-06 |
| 2011-10-02 | $358.00M 10-Q · filed 2011-11-04 |
| 2011-01-02 | $2.25M 10-Q · filed 2011-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |